"UPMC Hillman Cancer Center - Mt. Pleasant (Medical Oncology) is a Cancer Treatment Center located in Mount Pleasant.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Hillman Cancer Center - Part of Frick Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Hillman Cancer Center - Part of Frick Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "University of Pittsburgh" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Myriad Genetic Laboratories, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center - Part of Frick Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center - Part of Frick Hospital" are "Adenoid Cystic Carcinoma" (2 trials), "Stage IIIA Lung Cancer AJCC v8" (2 trials), "Stage IIIB Lung Cancer AJCC v8" (2 trials), "Thyroid Gland Carcinoma" (2 trials) and "ALK Gene Rearrangement" (1 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center - Part of Frick Hospital" in a lesser frequency.

Most popular intervention types in "UPMC Hillman Cancer Center - Part of Frick Hospital" are "Drug" (17 trials), "Biological" (9 trials), "Other" (9 trials), "Procedure" (9 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (7 trials), "Biospecimen Collection" (5 trials), "Carboplatin" (5 trials), "Paclitaxel" (5 trials) and "Magnetic Resonance Imaging" (4 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Hillman Cancer Center - Part of Frick Hospital" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Hillman Cancer Center - Part of Frick Hospital". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UPMC Hillman Cancer Center - Part of Frick Hospital, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Hillman Cancer Center - Part of Frick Hospital, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".